VentriPoint Diagnostics (VPTDF, $0.06) was a top loser over the last three months, falling -3 to $0.06 per share. A.I.dvisor analyzed 411 stocks in the Medical Specialties Industry for the 3-month period ending February 18, 2025, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.